Navigation Links
Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
Date:8/19/2007

- Zingo is First Commercial Product for Anesiva -

- Conference Call Scheduled for Today at 8:30 a.m. ET -

SOUTH SAN FRANCISCO, Calif., Aug. 17 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that the U.S. Food and Drug Administration (FDA) has approved Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection system, which provides rapid, topical, local analgesia to reduce the pain associated with venous access procedures, such as IV insertions or blood draws, in children ages three to 18. Zingo is an easy-to-administer, single-use, needle-free system containing 0.5 mg sterile lidocaine powder. It provides a rapid onset of action, allowing intravenous line placement or venipuncture to begin one to three minutes after administration.

"Blood draws and IV insertions are the most frequently reported painful events in hospitalized children. Despite guidelines recommending the use of topical anesthetics prior to venous access procedures, currently available local anesthetics commonly take 20 minutes or longer to act, making their use in today's fast-paced hospital environment difficult. FDA approval of Zingo provides a unique option for healthcare providers who strive to safely and effectively manage children's pain during these procedures," said John P. McLaughlin, chief executive officer of Anesiva. "Anesiva is committed to improving pain management, and the approval of Zingo marks an important step toward reaching this goal. This favorable decision by the FDA to approve Zingo came more than five weeks earlier than our PDUFA date of September 24th, and we are grateful for the efforts put in by the agency and for the cooperative relationship that w
'/>"/>

SOURCE Anesiva, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Lucigen receives $750K grant to boost biofuel yields
3. Medical College receives $1.4M cancer grant
4. Wisconsin biotech firm receives $107K NIH grant
5. InvivoSciences receives NIH grant for heart technology
6. Medical College receives $11 million grant to study high blood pressure
7. Madison business receives $115,000 of new state biofuels funding
8. Superior receives funds for technical training
9. UWM receives state funding for plastics research
10. GEs Centricity EHR receives federal certification
11. WHIE receives state eHealth Initiative contract

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... charge their cell phones and other personal elect...ry made by UC San Diego engineers could lead to ca...just this. , In recent research, published in ...fessor in the UCSD Department of Mechanical and Ae...ark Hoefer, have found that artificially introduce...
(Date:11/19/2009)...v. 19 Spherix Incorporat... for diabetes therapy, and a provider of technical...ement, biotechnology and pharmaceutical companies,... $6.3 million registered direct placement to insti...on stock and warrants to purchase up to 1,104,348 ...
(Date:11/19/2009)...mber 19 MONITORING FORCE GmbH,anno...Flibanserin in the,indication treatment-relevant l...for orphan drug status designation with the Europe...nesia is a complication of the mainstay,treatment ...me of those,affected, since it may be disabling fo...
(Date:11/19/2009)...ored by latest award for revolutionary hearing aid...vember 16, 2009 -- Popular Science Magazine has na...from InSound Medical a winner of its coveted Best ...nbsp;   Chosen from thousands of en...aring canal for up to four months while providing ...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
...tar,Therapeutics (Nasdaq: NKTR ) will announce it...rch 31, 2008 on Wednesday, May 7, 2008, after the,...n, president and chief,executive officer, will hos... Time (ET)., Investors can access the press relea... call through a link that is posted on the Investo...
... BTV8 vaccine released to supply Northern ...therlands, April 30 ,Intervet/Schering-Plough Anim...f Bovilis BTV8 vaccine against bluetongue to suppl...ombining after the acquisition in 2007 the,strengt...s not only the,world market leader in the producti...
... Squibb,Company (NYSE: BMY ) invites investors an... annual meeting with stockholders at 10 a.m. ET on...er and board items to be,transacted, senior execut...ess., For information on how to listen to the web...the Bristol-Myers Squibb website at, http://www.bm...
Other Biology Technology:Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets 2Intervet/Schering-Plough Animal Health Outlines Strength of the Combination 2Intervet/Schering-Plough Animal Health Outlines Strength of the Combination 3
(Date:11/22/2009)...ch Centre, a partnership of the University of Brit...stal Health Research Institute, have uncovered new...lls die following a stroke, as well as a possible ...udy were recently published online in Nature Medi...ntinue to die even after blood flow has been resto...
(Date:11/20/2009)...ead studies about the health benefits of having a ...lar level, where amino acids known as cysteines ar...when paired up with other cysteines. , Now, rese...colleagues in Belgium, have discovered a new antio...research appears in the Nov. 20 issue of the journ...
(Date:11/20/2009)...09) Scientists from the Marine Biogeochemistry an...earch Laboratory (NRL) organized and led a team of... expedition to initiate methane hydrate exploratio...riation of sediment contribution to Arctic climate... Polar Sea as a research platform, three cross-she...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2Saving the single cysteine: New antioxidant system found 2International expedition investigates climate change, alternative fuels in Arctic 2Echo Therapeutics Initiates Clinical Study of its New One Piece Symphony 28TM 29 tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 5982 1Echo Therapeutics Initiates Clinical Study of its New One Piece Symphony 28TM 29 tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 5982 2Echo Therapeutics Initiates Clinical Study of its New One Piece Symphony 28TM 29 tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 5982 3Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 5980 1Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 5980 2Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 5980 3Codexis Names Fernando Valle Research Fellow 5978 1Codexis Names Fernando Valle Research Fellow 5978 2
... Dust is one of several types of aerosols in the a...erstood ways. Dust scatters and absorbs solar radi...eract with cloud formation and other climate-affec...and Infrared Pathfinder Satellite Observation (CAL...erstanding of how clouds and aerosols interact. Li...
...eam at Worcester Polytechnic Institute (WPI) has r...onal Institutes of Health (NIH) for a project aime...skin cells into stem-like cells. If successful, th... straightforward method for replacing tissue lost ...tive diseases like diabetes and Parkinson,s. , Th...
...e cause of death in Europe and early diagnosis is ...hythm and electrical activity in real time using a...on about abnormalities and gives clues to the natu...-term monitoring inconvenient for patients as it ...onment for indeterminate periods of time. , Six ...
Other Biology News:AGU journal highlights -- Sept. 3, 2008 2AGU journal highlights -- Sept. 3, 2008 3AGU journal highlights -- Sept. 3, 2008 4AGU journal highlights -- Sept. 3, 2008 5AGU journal highlights -- Sept. 3, 2008 6AGU journal highlights -- Sept. 3, 2008 7NIH EUREKA award funds research at WPI aimed at turning adult skin cells into stem-like cells 2NIH EUREKA award funds research at WPI aimed at turning adult skin cells into stem-like cells 3NIH EUREKA award funds research at WPI aimed at turning adult skin cells into stem-like cells 4A home early warning system for cardiac patients 2
HeLa Cell Slide from ProSci, Inc
Anti-YAP, phospho (Ser127) Antibody, Unconjugated from Cell Signaling Technology
EL4 Cell Slide from ProSci, Inc
BALB/3T3 Cell Slide from ProSci, Inc
Biology Products: